DrugPatentWatch Database Preview
Patent: 10,035,843
Try a free trial
See Plans and Pricing
Summary for Patent: 10,035,843
| Title: | RSV-specific binding molecule |
| Abstract: | The invention provides antibodies and functional equivalents thereof which are capable of specifically binding RSV. Nucleic acid sequences encoding said antibody, as well as antibody producing cells and methods for producing said antibody are also provided. |
| Inventor(s): | Beaumont; Tim (Ouderkerk aan de Amstel, NL), Bakker; Adrianus Q. (Hoorn, NL), Yasuda; Etsuko (Amsterdam, NL) |
| Assignee: | MedImmune Limited (Cambridge, GB) |
| Application Number: | 15/042,656 |
| Patent Claims: | see list of patent claims |
Details for Patent 10,035,843
| Applicant | Tradename | Biologic Ingredient | Dosage Form | BLA | Number | Approval Date | Patent No. | Assignee | Estimated Patent Expiration | Status | Orphan | Source |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Medimmune | SYNAGIS | palivizumab | VIAL | 103770 | 001 | 1998-06-19 | Try a Free Trial | MedImmune Limited (Cambridge, GB) | 2029-10-06 | RX | search | |
| Medimmune | SYNAGIS | palivizumab | VIAL | 103770 | 002 | 1998-06-19 | Try a Free Trial | MedImmune Limited (Cambridge, GB) | 2029-10-06 | RX | search | |
| >Applicant | >Tradename | >Biologic Ingredient | >Dosage Form | >BLA | >Number | >Approval Date | >Patent No. | >Assignee | >Estimated Patent Expiration | >Status | >Orphan | >Source |
International Patent Family for US Patent 10,035,843
| Country | Patent Number | Publication Date |
|---|---|---|
| United States of America | 2012070446 | Mar 22, 2012 |
| United States of America | 2014093500 | Apr 03, 2014 |
| United States of America | 2016251412 | Sep 01, 2016 |
| >Country | >Patent Number | >Publication Date |
